With this program, you will learn about the latest developments in clinical psychiatry, delving into issues such as molecular genetics applied to child psychiatry" 

The current major advances in psychiatry and child psychiatry are motivated by the enormous prevalence of this type of disorders in the population. Therefore, in response to this problem, new treatments and diagnostic techniques have been developed, so that the discipline has become even more precise in recent years. This situation demands, on the part of the professionals, an immediate update that allows them to incorporate the best procedures in the psychiatric field into their work.

This Advanced master’s degree, therefore, is presented as a great option to get up to date in the discipline, and offers the specialist the most advanced contents on issues such as childhood fear anxiety disorder, classification of sleep and wakefulness disorders, catatonia, impulse control disorders, childhood language psychopathology or premenstrual dysphoric disorder, among many others.

In this way, physicians will be able to integrate the latest innovations in clinical psychiatry into their daily practice, and they will do so through a 100% online teaching system that will allow them to study at the time and place of their choice. No uncomfortable commuting to an academic center. No rigid schedules. In addition, you will have at your disposal a teaching staff of enormous prestige in this health field, which will ensure that the professional is updated in a convenient and effective way.

The best educational technology will be at your disposal to update you quickly and effectively: case studies, interactive summaries, master classes, video techniques..." 

This Advanced master’s degree in Clinical Psychiatry contains the most complete and up-to-date scientific program on the market. The most important features include:

• Practical cases presented by experts in medicine
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Special emphasis on innovative methodologies in Psychiatry
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection work
• Content that is accessible from any fixed or portable device with an Internet connection

A teaching staff of great international prestige will accompany you throughout the learning process, ensuring that you keep up to date with the latest advances in psychiatry" 

Its teaching staff includes professionals from the field of medicine, who bring to this program the experience of their work, as well as renowned specialists from leading societies and prestigious universities. 

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersive educational experience designed to prepare students for real-life situations. 

This program is designed around Problem-Based Learning, whereby students must try to solve the different professional practice situations that arise throughout the program. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced experts.  

TECH's teaching system will allow you to continue developing your professional work without interruptions, studying whenever and wherever you decide"

This program will allow you to delve into aspects such as clinical management in psychiatry and neuroimaging studies"

This Advanced master’s degree in Clinical Psychiatry is structured in 20 specialized modules and has been designed by leading experts in this medical discipline. Therefore, in this program, the professional will be able to delve into issues such as schizoaffective disorder, community intervention in child psychiatry, psychopathology of impulsivity, avoidant or restrictive eating disorder or bipolar disorders, among many others. 

A teaching staff of international prestige and a highly effective teaching methodology are combined with complete and up-to-date contents, ready to bring the psychiatry professional up to date in a comprehensive manner"  

Module 1. Schizophrenia and Other Psychotic Disorders 

1.1. Epidemiology

1.1.1. Risk Factors
1.1.2. Etiopathogenesis of Psychosis 

1.2. Classification 
1.3. Schizophrenia

1.3.1. Clinical Characteristics 

1.4. Schizoaffective Disorder

1.4.1. Clinical Characteristics 

1.5. Schizotypal Disorder

1.5.1. Clinical Characteristics 

1.6. Acute and Transitory Psychotic Disorder

1.6.1. Clinical Characteristics

1.7. Delusional Disorder

1.7.1. Clinical Characteristics 

1.8. Assessment and Diagnosis 
1.9. Differential Diagnosis  
1.10. Treatment 

Module 2. Mood Disorders

2.1. Bipolar Disorders I

2.1.1. Epidemiology
2.1.2. Risk Factors
2.1.3. Etiopathogenesis  

2.2. Bipolar Disorders II

2.2.1. Classification

2.2.1.1. Clinical Characteristics 
2.2.1.2. Type I Bipolar Disorder 
2.2.1.3. Type II Bipolar Disorder 

2.2.2. Cyclothymia 

2.3. Bipolar Disorders III

2.3.1. Assessment

2.3.1.1. Diagnosis

2.3.2. Differential Diagnosis

2.4. Bipolar Disorders IV

2.4.1. Evolution
2.4.2. Prognosis

2.5. Bipolar Disorders V

2.5.1. Treatment

2.6. Depressive Disorders I

2.6.1. Epidemiology

2.6.1.1. Risk Factors

2.6.2. Etiopathogenesis

2.7. Depressive Disorders II

2.7.1. Classification
2.7.2. Clinical Characteristics

2.7.2.1. Depressive Disorder, Single Episode
2.7.2.2. Recurring Depressive Disorder
2.7.2.3. Dysthymic Disorder
2.7.2.4. Mixed Anxiety and Depression Disorder

2.7.3. Premenstrual Dysphoric Disorder

2.8. Depressive Disorders III

2.8.1. Assessment

2.8.1.1. Diagnosis

2.8.2. Differential Diagnosis

2.9. Depressive Disorders IV

2.9.1. Evolution
2.9.2. Prognosis

2.10. Depressive Disorders V

2.10.1. Treatment

Module 3. Anxiety or Fear-Related Disorders. Disorders Specifically Related to Stress. Dissociative Disorders

3.1. Anxiety or Fear-Related Disorders I

3.1.1. Epidemiology
3.1.2. Risk Factors
3.1.3. Etiopathogenesis

3.2. Anxiety or Fear-Related Disorders II

3.2.1. Classification
3.2.2. Clinical Characteristics

3.3. Anxiety or Fear-Related Disorders III

3.3.1. Assessment
3.3.2. Diagnosis
3.3.3. Differential Diagnosis

3.4. Anxiety or Fear-Related Disorders IV

3.4.1. Treatment

3.5. Disorders Specifically Related to Stress

3.5.1. Classification
3.5.2. Clinical Characteristics

3.6. Disorders Specifically Related to Stress II

3.6.1. Assessment
3.6.2. Diagnosis
3.6.3. Differential Diagnosis

3.7. Disorders Specifically Related to Stress III

3.7.1. Treatment

3.8. Dissociative Disorders I

3.8.1. Classification
3.8.2. Clinical Characteristics

3.9. Dissociative Disorders II

3.9.1. Assessment
3.9.2. Diagnosis
3.9.3. Differential Diagnosis

3.10. Dissociative Disorders III

3.10.1. Treatment
3.10.2. Prognosis

Module 4. Obsessive-Compulsive Disorder and Related Disorders 

4.1. Obsessive Compulsive Disorder I

4.1.1. Epidemiology
4.1.2. Risk Factors
4.1.3. Etiopathogenesis

4.2. Obsessive Compulsive Disorder III

4.2.1. Assessment
4.2.2. Diagnosis
4.2.3. Differential Diagnosis 

4.3. Obsessive Compulsive Disorder III

4.3.1. Treatment
4.3.2. Prognosis 

4.4. Body Dysmorphic Disorder I

4.4.1. Epidemiology
4.4.2. Risk Factors
4.4.3. Etiopathogenesis

4.5. Body Dysmorphic Disorder II

4.5.1. Assessment
4.5.2. Diagnosis
4.5.3. Differential Diagnosis 

4.6. Body Dysmorphic Disorder III

4.6.1. Treatment
4.6.2. Prognosis 

4.7. Hypochondriasis I

4.7.1. Epidemiology
4.7.2. Risk Factors
4.7.3. Etiopathogenesis 

4.8. Hypochondriasis II

4.8.1. Assessment
4.8.2. Diagnosis
4.8.3. Differential Diagnosis 

4.9. Hypochondriasis III

4.9.1. Treatment
4.9.2. Prognosis 

4.10. Other Disorders

4.10.1. Olfactory Reference Disorder
4.10.2. Hoarding Disorder
4.10.3. Body-Centered Repetitive Behavior Disorders  

Module 5. Eating Disorders 

5.1. Epidemiology

5.1.1. Risk Factors
5.1.2. Etiological Factors 

5.2. Classification  
5.3. Anorexia

5.3.1. Clinical Characteristics 

5.4. Bulimia

5.4.1. Clinical Characteristics 

5.5. Binge Eating Disorder

5.5.1. Clinical Pathologies 

5.6. Assessment

5.6.1. Diagnosis
5.6.2. Differential Diagnosis 

5.7. Medical Aspects of Assertive Community Treatment

5.7.1. Medical Complications
5.7.2. Medical Assessment
5.7.3. Analytical Results 

5.8. Medical Treatment 
5.9. Psychotherapeutic treatment 
5.10. Other Specific Eating Disorders

5.10.1. Avoidant or Restrictive Eating Disorder
5.10.2. PICA Syndrome
5.10.3. Rumination or Regurgitation Disorder

Module 6. Disorders Due to Substance Use or Addictive Behavior

6.1. Disorders Due to Alcohol Consumption 
6.2. Disorders Due to Cannabis Consumption  
6.3. Disorders Due to Opioids Consumption 

6.3.1. Heroin 
6.3.2. Opioids Subject to Medical Prescription 

6.4. Disorders Due to Cocaine Consumption  
6.5. Disorders Due to Stimulants Consumption 
6.6. Other Drugs

6.6.1. Synthetic Cathinones
6.6.2. Hallucinogens
6.6.3. MDMA
6.6.4. Dissociative Drugs (PCP and Ketamine)
6.6.5. Inhalants 

6.7. Disorders Due to Sedatives Consumption

6.7.1. Hypnotics
6.7.2. Anxiolytics 

6.8. Disorders Due to Nicotine Consumption 
6.9. Disorders Due to Caffeine Consumption  
6.10. Disorders Due to Addictive Behavior 

6.10.1. Betting Disorders 
6.10.2. Disorders Due to Video Game Use  

Module 7. Personality Disorders and Related Features

7.1. Theories of Personality 
7.2. Personality: Traits Versus Disorder 
7.3. Classifications of Personality Disorders 
7.4. Epidemiology  
7.5. Etiopathogenesis
7.6. Clinical Forms 
7.7. Emotional Instability Disorder 
7.8. Comorbidities in Personality Disorders 
7.9. Evaluation, Diagnosis and Differential Diagnosis 

7.9.1. Diagnosis
7.9.2. Differential Diagnosis 

7.10. Treatment 

Module 8. Neurocognitive Disorders

8.1. Classification 
8.2. Delirium: Epidemiology 

8.2.1. Risk Factors
8.2.2. Etiopathogenesis 

8.3. Delirium: Evaluation

8.3.1. Diagnosis
8.3.2. Differential Diagnosis 

8.4. Delirium: Treatment 

8.4.1. Non-Pharmacological 
8.4.2. Pharmacological  

8.5. Dementia

8.5.1. Common Aspects  

8.6. Dementia Due to Alzheimer's Disease  
8.7. Dementia Due to Cerebrovascular Disease   
8.8. Dementia due to Lewy Body Dementia  
8.9. Frontotemporal Dementia  
8.10. Other Specified Neurocognitive Disorders

8.10.1. Mild Neurocognitive Disorder
8.10.2. Amnestic Disorder
8.10.3. Secondary Neurocognitive Syndrome 

Module 9. Sleep and Wakefulness Disorders

9.1. Normal Sleep

9.1.1. Basic Aspects 

9.2. Diagnostic Assessment 
9.3. Classification of Sleep and Wakefulness Disorders 
9.4. Insomnia I

9.4.1. Clinical Symptoms
9.4.2. Assessment 

9.5. Insomnia II

9.5.1. Medical Treatment 

9.6. Insomnia III

9.6.1. Non-Pharmacological Treatment 

9.7. Hypersomnia Disorders 
9.8. Disorders of the Circadian Rhythm of Sleep and Wakefulness 
9.9. Parasomnia Disorders 
9.10. Monitoring Sleep 

Module 10. Other Disorders

10.1. Catatonia 
10.2. Impulse Control Disorder 
10.3. Factitious Disorder  
10.4. Mental or Behavioral Disorders Associated with Pregnancy

10.4.1. Birth
10.4.2. Post-Partum

10.5. Paraphilic Disorders
10.6. Sexual Dysfunctions 
10.7. Attention Deficit Disorder

10.7.1. Hyperactivity 

10.8. Gender Conflict 
10.9. Psychological or Behavioral Factors that Affect Illnesses or Diseases Classified in Another Part   
10.10. Secondary Mental Health or Behavioral Syndromes Associated With Illnesses or Disorders Classified in Another Part  

Module 11. Psychiatry in the Different Stages of Life

11.1. Social and Personality Development

11.1.1. Attachment
11.1.2. Play
11.1.3. Self-Esteem
11.1.4. Treatment and Character
11.1.5. Personality

11.2. Perinatal Psychiatry

11.2.1. Intrauterine Development Fetus-Mother Interactions Effects of Stress
11.2.2. Psychological Support

11.2.2.1. In Assisted Reproduction
11.2.2.2. In At-Risk Pregnancies
11.2.2.3. In Prenatal Diagnosis

11.2.3. Early Detection and Intervention

11.2.3.1. Depression in Pregnancy: Mother and Child
11.2.3.2. Secondary Effects of Medication and Drugs During the Prenatal Period

11.3. Psychiatry in Birth

11.3.1. Psychological Support

11.3.1.1. In the Preparation for Giving Birth
11.3.1.2. In Premature Births
11.3.1.3. In Traumatic Births
11.3.1.4. In Perinatal Deaths: Mother or Child

11.3.2. Early Detection and Intervention

11.3.2.1.  Baby Blues and Postpartum Depression: Mother and Child
11.3.2.2. Postpartum Psychosis

11.4. The First 1000 Days

11.4.1. Presentation of the Newborn
11.4.2. Characteristics of Development from 2 Months to 3 Years Old
11.4.3. The Role of Interaction With the Main Caregiver in the Development During the First Years of Life
11.4.4. How to Assess These First Years
11.4.5. Diagnostic Classification of Mental Health and of the Development Disorders

11.5. Pre-school Stage

11.5.1. General Overview of the Clinical Interview
11.5.2. Diagnostic Interview
11.5.3. Characteristics of the Early Childhood Interview

11.6. School Stage

11.6.1. Maturation of the Nervous System
11.6.2. Motor Development
11.6.3. Acquisition of Language
11.6.4. Cognitive Development
11.6.5. Feeding
11.6.6. Sleep
11.6.7. Self-Concept
11.6.8. Self-Esteem
11.6.9. Morality
11.6.10. Psychosexual Development
11.6.11. Family and Age Development
11.6.12. Influence of Peers During the Development at School Age

11.7. Puberty and Adolescence

11.7.1. Physiological Changes
11.7.2. Psychological Changes
11.7.3. Neurobiological Changes
11.7.4. Psychiatric Pathology in Adolescence
11.7.5. Self-harm and Suicidal Behavior
11.7.6. Transition in Medical Care

11.8. Young Adult (18-24 years old)

11.8.1. Psychological Development in Young Adults
11.8.2. Approach to Mental Disorders in Young Adults

11.9. Building a Family

11.9.1. Formation and Elements of the Family
11.9.2. Stages of the Family
11.9.3. Family Functions
11.9.4. Therapy

11.10. Specific Areas of Development

11.10.1. Motor Development
11.10.2. Social-Emotional Development
11.10.3. Cognitive Development
11.10.4. Development of Attention, Perception and Memory
11.10.5. Communication Development
11.10.6. Language and Speaking Development
11.10.7. Emotional Intelligence Development
11.10.8. Identity Development
11.10.9. Moral Development
11.10.10. Psychosexual Development

Module 12. Clinical Syndromes in Childhood and Adolescent Psychiatry

12.1. Diagnostic Taxonomies

12.1.1. Definition
12.1.2. Historical Introduction
12.1.3. Current Classification Systems

12.2. Abuse and Addictions

12.2.1. Alcohol and Drugs
12.2.2. Behavioral Addictions
12.2.3. Dual Pathologies

12.3. Eating Disorders

12.3.1. Etiology
12.3.2. Clinical Assessment

12.3.2.1. Clinical Features in Anorexia Nervosa
12.3.2.2. Clinical Features in Bulimia Nervosa
12.3.2.3. Complementary Evaluations

12.3.3. Diagnosis
12.3.4. Treatment

12.3.4.1. Nutritional Treatment
12.3.4.2. Psychological Treatment
12.3.4.3. Medical treatment

12.3.5. Prevention

12.4. The Environment in Child Psychiatry

12.4.1. School Bullying
12.4.2. Adaptation Disorders
12.4.3. Post-Traumatic Stress Disorder
12.4.4. Treatment of PTSD
12.4.5. Parental Alienation Syndrome
12.4.6. Bonding Disorders
12.4.7. Reactive Attachment Disorder
12.4.8. Disinhibited Social Relationship Disorder

12.5. Mood Disorder

12.5.1. Depression
12.5.2. Grief
12.5.3. Bipolar Disorder

12.6. Anxiety Disorder

12.6.1. Childhood Fears and Simple Phobias
12.6.2. Separation Anxiety Disorder
12.6.3. Selective Mutism
12.6.4. Generalized Anxiety Disorder
12.6.5. Social Anxiety Disorder
12.6.6. Panic Attacks and Panic Disorder

12.7. Autism and Social Community Disorder

12.7.1. Autism Spectrum Disorder
12.7.2. Social Communication Disorder (Pragmatic)

12.8. Cognition Disorder

12.8.1. Borderline Intellectual Level
12.8.2. Intellectual Disability
12.8.3. Childhood Dementia

12.9. Basic Instincts

12.9.1. Aggressiveness

12.9.1.1. Self-Aggression
12.9.1.2. Hetero-Aggressiveness

12.9.2. Sphincters

12.9.2.1. Encopresis
12.9.2.2. Enuresis

12.9.3. Sexuality

12.9.3.1. Sexual Problems in Children and Adolescents
12.9.3.2. Atypical Psychosexual Development

12.9.4. Sleep

12.9.4.1. Parasomnia
12.9.4.2. Dyssomnia

12.10. Psychotic Disorders

12.10.1. Terms
12.10.2. Epidemiology
12.10.3. Etiology
12.10.4. Clinical Symptoms
12.10.5. Diagnostic Evaluation and Differential Diagnosis
12.10.6. Treatment and Approach
12.10.7. Course and Prognosis

12.11. Obsessive Compulsive Disorder

12.11.1. Epidemiology
12.11.2. Etiology
12.11.3. Pathophysiology
12.11.4. Manifestations and Clinical Course Clinical Differences with OCT in Adults
12.11.5. Differential Diagnosis
12.11.6. Comorbidity
12.11.7. Treatment

12.12. Personality Disorders

12.12.1. Prevalence of Personality Disorders in Children and Adolescents
12.12.2. Clinical Manifestations
12.12.3. Cormorbidity and Prognosis
12.12.4. Diagnosis
12.12.5. Intervention and Treatment

12.13. Other Disorders

12.13.1. Learning Disorders
12.13.2. Speaking Disorder
12.13.3. Language Disorder
12.13.4. Reading Disorder
12.13.5. Motor Disorders
12.13.6. Other Non-Mental Disorders

12.14. Behavioral Disorders I. Tics, Tourette’s and ADHD

12.14.1. Tics
12.14.2. Tourette’s Syndrome
12.14.3. Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents

12.15. Behavioral Disorders II. Disruptive, Impulsive or Antisocial Personality

12.15.1. Epidemiology
12.15.2. Etiology
12.15.3. Disruptive Behavior Disorders
12.15.4. Antisocial Personality Disorder
12.15.5. Impulse Control Disorder
12.15.6. Management

Module 13. Psychopathology in Childhood

13.1. Perception Psychopathology

13.1.1. Perceptive Function Disorders
13.1.2. Perception Anomalies
13.1.3. Hallucinations
13.1.4. Pseudohallucinations
13.1.5. Hallucinosis

13.2. Thought Disorders

13.2.1. Magical Thinking and Logical Thinking
13.2.2. Psychopathology
13.2.3. Disorders of Thought Content
13.2.4. Formal and Thought Control Disorders

13.3. Language Psychopathology

13.3.1. Language Disorders
13.3.2. Language Disorders in Childhood
13.3.3. Communication Disorders According to thDSM-5 Classification
13.3.4. Language Psychopathology in Childhood
13.3.5. Acquired Aphasia with Epilepsy or Landau-Kleffner Syndrome

13.4. Psychopathology of Affectivity

13.4.1. Affective Symptoms
13.4.2. Psychopathology of Affectivity in Adolescence
13.4.3. Syndromic Alterations of Affectivity

13.5. Psychopathology of Psychomotor Skills

13.5.1. Increase in Psychomotor Activity
13.5.2. Reduction in Psychomotor Activity
13.5.3. Abnormalities of Mimic and Body Expression

13.6. Psychopathology of Sleep

13.6.1. Physiology of Sleep
13.6.2. Dyssomnia
13.6.3. Parasomnia

13.7. Psychopathology of Intelligence

13.7.1. Definition of Intelligence
13.7.2. Psychopathology

13.7.2.1. Intellectual Deficiency
13.7.2.2. Development Disability
13.7.2.3. Inhibitions or Blocks

13.8. Psychopathology of Nutritional Instincts

13.8.1. Symptomatic Eating Disorders
13.8.2. Primary Eating Disorders

13.9. Psychopathology of the Sex Life

13.9.1. Psychosexual Development and Sex Life
13.9.2. DSM-5 and its Classification of Sexuality Disorders

13.10. Psychopathology of Impulsiveness

13.10.1. An Impulsive Child
13.10.2. Approach to Impulsiveness
13.10.3. Etiological Formulations: Biological, Psychological and Psychosocial Factors of Impulsiveness
13.10.4. Impulsiveness as a Symptom for Other Child and Adolescent Disorders
13.10.5. Changes in the Diagnostic and Statistical Manual DMS-5
13.10.6. Approach and Treatment

13.11. Psychopathology of Insight

13.11.1. Models and Dimensions of Insight
13.11.2. Insight in Mental Disorders

13.12. Psychopathology of Conscience and Attention

13.12.1. Psychopathology of Conscience
13.12.2. Quantitative Alterations
13.12.3. Qualitative Alterations
13.12.4. Psychopathology of Attention

13.13. Psychopathology of Memory

13.13.1. Basic Psychopathological Concepts

13.14. Psychopathology of Aggression

13.14.1. Classification
13.14.2. Theories
13.14.3. Evolutionary Development of Aggression
13.14.4. Aggression Modulators

Module 14. New Advances in Childhood Psychiatry

14.1. Epidemiology of Mental Disorders in Childhood and Adolescence

14.1.1. Uses and Limitations of Epidemiological Studies
14.1.2. Measurements of the Frequency of Illnesses
14.1.3. Types of Epidemiological Studies
14.1.4. Prevalence of Mental Disorders in Childhood and Adolescence The Question of the Classification Systems of Illnesses
14.1.5. Comorbidity
14.1.6. Continuity in Adulthood

14.2. Genetic Advances in Childhood Psychiatry

14.2.1. Approach to Molecular Genetics
14.2.2. From Genetics to Symptomology
14.2.3. Future of Genetics in Child and Adolescent Psychiatric Research

14.3. Update on Neurochemistry in Psychiatry

14.3.1. Neurobiology of Development: Genetic Implication
14.3.2. Neurochemistry of Early Development
14.3.3. Neurochemistry of Learning
14.3.4. Neurochemistry of the Reward System
14.3.5. Neurochemistry in Aggression

14.4. Clinical Psychophysiology and Neurophysiology: Application in Practice

14.4.1. Videoelectroencephalography (VEEG)
14.4.2. Normal Sleep in Childhood and Adolescence
14.4.3. Nocturnal Video-Polysomnography (VPSG)
14.4.4. Cognitive Evoked Potentials (CEP)

14.5. Scientific Research in Psychiatry

14.5.1. Epidemiology: Basic Concepts
14.5.2. Bioethics of Clinical Research and of the Professional/Patient Relationship
14.5.3. Evidence-Based Medicine
14.5.4. Objectives of the Research: How to Formulate Research Questions and Search Strategies
14.5.5. Phases of a Research Project Definition of Variable, Design and Type of Study
14.5.6. Study Population: Sample Size and Sample Selection
14.5.7. Analysis and Management of Data

14.6. Efficient Communication and Leadership in Psychiatry

14.6.1. Common Aspects
14.6.2. Written Texts
14.6.3. Oral Reports

Module 15. Liaison and Interconsultation Psychiatry: Psychosomatic Paidopsychiatry

15.1. Chronic Pediatric Illness

15.1.1. Psychological Impact
15.1.2. Related Factors
15.1.3. Therapeutic Intervention

15.2. The Child and the Family in the Face of Illness and Death

15.2.1. The Child and the Family in the Face of Illness and Hospitalization
15.2.2. The Child and the Family in the Face of Death

15.3. Psychosomatic Paidopsychiatry in Pediatric Oncohematology

15.3.1. Psychopathological Alterations in Children With Cancer
15.3.2. Diagnosis
15.3.3. Treatment

15.4. Psychosomatic Paidopsychiatry in Pediatric Endocrinology

15.4.1. Obesity
15.4.2. Diabetes

15.5. Psychosomatic Paidopsychiatry in Pediatric Nephrology

15.5.1. Chronic Kidney Disease: Concept and Most Common Causes
15.5.2. Psychiatric Disorders Associated with CKD in Children and Adolescents
15.5.3. Renal Transplant

15.6. Psychosomatic Paidopsychiatry in Neurology

15.6.1. Headaches
15.6.2. Epilepsy

15.7. Psychosomatic Paidopsychiatry in Pediatric Cardiology

15.7.1. Psychosocial Problems
15.7.2. Psychiatric Disorders in Congenital Heart Disease

15.8. Psychosomatic Paidopsychiatry in Children and Adolescents: Burns Victims

15.8.1. Psychosocial Adjustment
15.8.2. Therapeutic Considerations

15.9. Psychosomatic Paidopsychiatry of Children in the ICU

15.9.1. Types of Pediatric Intensive Care Units
15.9.2. Psychopathology
15.9.3. Treatment and Interventions

15.10. Delirium

15.10.1. Epidemiology
15.10.2. Etiology
15.10.3. Neuropathogenesis
15.10.4. Clinical Manifestations
15.10.5. Diagnosis
15.10.6. Treatment

15.11. Suicidal Behavior from the Interconsultation Point of View

15.11.1. Concept of Death and Illness in Children and Adolescents
15.11.2. Concept of Suicide
15.11.3. Characteristics of the Interconsultation of Suicidal Behavior
15.11.4. Assessment
15.11.5. Therapeutic Approach
15.11.6. Absolute Indicators of Admission (or Maintaining Admission)

15.12. Intervention and Pain Management and Preparation of Invasive Interventions in Children and Adolescents

15.12.1. Psychological Intervention for the Preparation of Invasive Interventions
15.12.2. Relaxation Technique

15.13. Psychosomatic Paidopsychiatry

15.13.1. Special Characteristics for Psychosomatic Paidopsychiatry
15.13.2. Psychosomatic Paidopsychiatry
15.13.3. Interconsultation Times in Psychosomatic Paidopsychiatry
15.13.4. Most Frequent Problems and Pathologies

15.14. Psychopharmacology in the Interconsultation

15.14.1. Pediatric Psychopharmacology or Development First Principles
15.14.2. Psychpharmacology in Pediatric Illnesses

15.15. Psychosomatic Paidopsychiatry in Pediatric Gastroenterology

15.15.1. Repetitive Abdominal Pain
15.15.2. Chronic Inflammatory Bowel Disease
15.15.3. Ulcerative Colitis
15.15.4. Coeliac Disease

15.16. Psychosomatic Paedopsychiatry in Pediatric Pneumology

15.16.1. Asthma
15.16.2. Cystic Fibrosis

Module 16. Advances in Treatments in Child and Adolescent Psychiatry

16.1. Environmental Treatments

16.1.1. Third Generation Therapies

16.2. Behavioral Treatment

16.2.1. Cognitive Behavioral Therapy
16.2.2. Parent Training
16.2.3. Family Therapy (Systemic)
16.2.4. Individual Psychotherapy
16.2.5. Group Psychotherapy

16.3. Psychoanalysis

16.3.1. Psychoanalytical Technique
16.3.2. Indications of Psychoanalysis
16.3.3. Results of Psychoanalysis
16.3.4. Psychoanalytical Psychotherapy

16.4. Pharmacological Treatment. Dose and Application

16.4.1. Mechanisms of Action for Drugs
16.4.2. Precautions, Warnings and Informed Consent

16.5. Surgical Treatments

16.5.1. Sex Reassignment Surgery (SRS)
16.5.2. Neurosurgery

16.6. Technological Treatment EBM Recommendations

16.6.1. Technological Treatment
16.6.2. EBM Therapeutic Recommendations

Module 17. Child and Adolescent Psychiatric Emergencies

17.1. Emergency Diagnosis and Urgent Report

17.1.1. Definition and Epidemiology of Psychiatric Emergencies
17.1.2. Evaluation of Emergencies
17.1.3. Differential Diagnosis and Psychomotor Agitation

17.2. Anxiety Syndrome

17.2.1. Anxiety Disorders
17.2.2. Anxiety Syndrome in Emergencies

17.3. Non-Suicidal Self-Harm

17.3.1. Risk Factors
17.3.2. Explanatory Models
17.3.3. How to Act from a Pediatric Emergency Department
17.3.4. Current Treatments

17.4. Approach to Suicidal Behaviour from Pediatric Emergency Departments

17.4.1. Risk Factors and Protection
17.4.2. Explanatory Models
17.4.3. How to Act from a Pediatric Emergency Department
17.4.4. Current Psychological Treatment

17.5. Motor Agitations

17.5.1. Patient Evaluation
17.5.2. Etiology and Diagnosis
17.5.3. Approach and Treatment

17.6. Psychotic Picture

17.6.1. Epidemiology
17.6.2. Etiology
17.6.3. Clinical Symptoms
17.6.4. Diagnostic Evaluation and Differential Diagnosis
17.6.5. Treatment and Approach
17.6.6. Course and Prognosis

17.7. Substance Abuse Problems

17.7.1. Etiology and Epidemiology
17.7.2. Types of Substances
17.7.3. Clinical Symptoms
17.7.4. Differential Diagnosis
17.7.5. Treatment

17.8. Family Conflicts

17.8.1. Physical Space and First Contact
17.8.2. Family Conflict and Lawsuit
17.8.3. Family Structure and Configuration
17.8.4. Life Cycle
17.8.5. Elaboration of a Diagnostic Hypothesis on the Family Conflict
17.8.6. Family Interventions

17.9. Bullying

17.9.1. Detection
17.9.2. Intervention
17.9.3. Prevention
17.9.4. Final Reflections

17.10. Sexual Abuse

17.10.1. Types of Child Maltreatment
17.10.2. Classification of Child Sexual Abuse
17.10.3. Characteristics of Child Sexual Abuse
17.10.4. Evaluation of a Possible Case of Child Sexual Abuse

Module 18. Professional Skills in Child Psychiatry

18.1. The Clinical Interview

18.1.1. Types of Interviews
18.1.2. Parent Interview
18.1.3. Interview and Examination Elements in Children
18.1.4. Child Play and Drawing
18.1.5. Adolescent Interview
18.1.6. Interview of Other Adults

18.2. Child Examination

18.2.1. Physical Examination

18.2.1.1. Physical Examination
18.2.1.2. Medical Examination
18.2.1.3. Significance of Lesser Neurological Symptoms
18.2.1.4. Neuroimaging Studies in Child and Adolescent Psychiatry

18.2.2. Psychological/Mental Health Examination

18.2.2.1. Cognitive Examination
18.2.2.2. Emotional Examination
18.2.2.3. Social Examination
18.2.2.4. Instrumental Examination
18.2.2.5. Interpretive Instruments

18.2.3. Psychopathological Examination

18.3. Neuroimaging and Other Complementary Studies

18.3.1. Magnetic Resonance
18.3.2. Neuroimaging Techniques Using Radiotracers PET/SPECT

18.4. The Diagnostic Process and Reasoning

18.4.1. Diagnostic Evaluation What and Why?
18.4.2. Functional Analysis of Behavior

Module 19. Clinical Management of Psychiatry

19.1. General Principles, Guidelines, Plans and Programs Reference Models

19.1.1. Principles and Reference Guidelines for Caring for Minors with Psychic Problems
19.1.2. Plans and Programs on Mental Health of Children and Adolescents
19.1.3. Reference Models

19.2. Recipients, Service Portfolio, Health Care Network and Health Care Processes

19.2.1. Recipients
19.2.2. Portfolio of services
19.2.3. Health Care Network
19.2.4. Health Care Processes

19.3. Professional Teams and Profiles, Coordination, Management Tools and Indicators

19.3.1. Professional Teams and Professional Profiles
19.3.2. Coordination
19.3.3. Management Tools
19.3.4. Indicators

Module 20. Community Intervention in Childhood Psychiatry

20.1. School

20.1.1. Attention to Diversity
20.1.2. Characteristics and Strategies for Care of Different Mental Disorders in the School Environment

20.2. Social Services

20.2.1. Early Care
20.2.2. High Risk Families
20.2.3. Interventions in Multi-Problematic Families
20.2.4. Maltreatment and Neglect
20.2.5. Boarding and Lodging
20.2.6. Adoption

20.3. Medical-Legal Aspects of Childhood Psychiatry

20.3.1. Legal Aspects in Clinical Practice
20.3.2. Divorce, Separation and New Forms of Cohabiting
20.3.3. Psychiatric Hospitalization of Children and Adolescents
20.3.4. Mental Health in the Juvenile Justice System
20.3.5. Bad Practice (Iatrogenic) and Professional Liability
20.3.6. Testifying in a Court of Law

20.4. Mental Health in Adults

20.4.1. Transition Between Services
20.4.2. First Psychotic Episodes
20.4.3. ADHD and Autism After 18 Years of Age

This program will allow you to learn about the latest innovations in clinical management in psychiatry"